HCMV was also demonstrated to inhibit the induction of HLA class II antigens by IFN-beta dependent and independent molecules including ICAM-1 and VCAM-1, which are thought to be involved in MS pathogenesis [29]. The gene discussed is VCAM1; the disease is myeloid sarcoma.